Literature DB >> 31859725

Surgical breast incisions treated with 2-octyl-cyanoacrylate versus intradermal nylon suture: a randomized clinical trial.

Ruffo de Freitas Júnior1, Thiago Silva Becker1, Rosemar Macedo Sousa Rahal1, Regis Resende Paulinelli1, Leonardo Ribeiro Soares1.   

Abstract

OBJECTIVE: to evaluate the safety profile and aesthetic results of 2-octyl-cyanoacrylate versus intradermal nylon suture in breast surgeries.
METHODS: an open-label, randomized, clinical trial evaluating the occurrence of complications, such as dehiscence, hematoma, infection, and allergic reactions after the use of 2-octyl-cyanoacrylate or nylon thread. The size of the incisions, skin closure time, and total surgical time were also analyzed. The aesthetic outcome was evaluated at 40 and 180 days after surgery, by means of the average width of the surgical wound and by subjective conceptual assessment (optimal, good, reasonable, or poor).
RESULTS: 79 patients were included: 37 in the 2-octyl-cyanoacrylate group and 42 in the nylon suture group. The study was stopped before the end of patient recruitment due to the occurrence of a greater number of dehiscences in the adhesive group (OR: 11.42; 95%CI: 1.36-96.02; p=0.007). Regarding the other analyzed complications, the surgical duration and postoperative aesthetic result, no significant differences were observed between the groups. The mean operative wound size was greater in the adhesive group than in the suture group, but there was no correlation between wound size and the largest number of dehiscences.
CONCLUSION: while the cosmetic outcomes with the two techniques were similar, there was a greater risk of dehiscence with the use of 2-octyl-cyanoacrylate compared to intradermal suturing.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31859725     DOI: 10.1590/0100-6991e-20192286

Source DB:  PubMed          Journal:  Rev Col Bras Cir        ISSN: 0100-6991


  1 in total

1.  Observation of Wound Healing Effect and Aesthetic Satisfaction of Patient with Second Degree Burn Wounds Treated by Kangfuxin Solution.

Authors:  Changhai Liu; Yuren Zhong; Cuie Wei; Fanjun Meng; Yongdong Pei; Xiangsheng Ding
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-07       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.